17β-雌二醇减弱了压力过载过度增强的发展
M van Eickels1, C Grohé, J P Cleutjens
1Cardiovascular Research Institute Maastricht, University of Maastricht, Netherlands. mvaneickels@lifespan.org
Circulation
|September 19, 2001
概括
用17β-雌激醇 (E(2) 进行雌激素替代疗法,有效降低小鼠心脏缩. 这种激素替代疗法具有直接的心脏作用,通过减轻心脏膨胀,可能有利于绝经后妇女.
科学领域:
- 心脏病学 心脏病学
- 内分泌学 在内分泌学.
- 分子生物学分子生物学
背景情况:
- 心脏缩是心血管疾病的重要危险因素.
- 雌激素替代疗法 (ERT) 显示出心脏保护作用,但机制尚不清楚.
- 17β-雌激醇 (E(2)) 是一种关键的雌激素激素.
研究的目的:
- 研究17β-雌二醇 (E(2) 对压力过载引起的心脏缩的作用.
- 阐明E(2) 的心脏保护作用背后的分子机制.
主要方法:
- 卵巢切除的小鼠接受了横向大动脉收缩 (TAC) 或假手术.
- 小鼠接受了E(2) 或安慰剂治疗.
- 分析了心脏质量,血液动力学,蛋白质酸化 (p38 MAPK,ERK1/2,JNK1/2) 和基因表达 (ACE,AT1R,ANP).
主要成果:
- 在TAC后,E(2) 治疗显著减少了26-31%的心脏缩.
- ) 阻断了p38-mitogen激活蛋白激酶 (MAPK) 的增加酸化.
- E(2) 在压力过重的心脏中增加了心房 natriuretic (ANP) 表达.
结论:
- 17β-雌二醇 (E(2)) 在应对压力过载时减轻心脏缩.
- 带有E(2) 的ERT对心脏有直接的有益影响.
- 激素替代疗法可能是减少绝经后妇女心脏缩的可行策略.
相关概念视频
Antihypertensive Drugs: Action of β1 Blockers
2.2K
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
2.2K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
2.1K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
2.1K
Hormonal Regulation of Blood Pressure
7.9K
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
7.9K
Heart Failure II: Pathophysiology
2.3K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
2.3K
Hypertension II: Pathophysiology
1.8K
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.8K
Cellular Adaptation II: Hypertrophy
78
Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy:...
78


